104 related articles for article (PubMed ID: 28009152)
21. T-regulatory cells in COPD or tumour environment.
Domagala-Kulawik J; Maskey-Warzecowska M
Eur Respir J; 2009 Jul; 34(1):284; author reply 285-6. PubMed ID: 19567614
[No Abstract] [Full Text] [Related]
22. Myeloid-Derived Suppressor Cells: Possible Link Between Chronic Obstrucive Pulmonary Disease and Lung Cancer.
Scrimini S; Pons J; Sauleda J
Arch Bronconeumol; 2016 Jan; 52(1):29-35. PubMed ID: 26321390
[TBL] [Abstract][Full Text] [Related]
23. High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer.
Leidinger P; Brefort T; Backes C; Krapp M; Galata V; Beier M; Kohlhaas J; Huwer H; Meese E; Keller A
Oncotarget; 2016 Jan; 7(4):4611-23. PubMed ID: 26672767
[TBL] [Abstract][Full Text] [Related]
24. Neoantigens in Chronic Obstructive Pulmonary Disease and Lung Cancer: A Point of View.
Zeneyedpour L; Dekker LJM; van Sten-van T Hoff JJM; Burgers PC; Ten Hacken NHT; Luider TM
Proteomics Clin Appl; 2019 Mar; 13(2):e1800093. PubMed ID: 30706659
[TBL] [Abstract][Full Text] [Related]
25. Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease.
Deepak JA; Ng X; Feliciano J; Mao L; Davidoff AJ
Ann Am Thorac Soc; 2015 May; 12(5):742-51. PubMed ID: 25760983
[TBL] [Abstract][Full Text] [Related]
26. Surgical treatment for lung cancer with COPD based on the Global Initiative for Chronic Obstructive Lung Disease (GOLD).
Iwasaki A; Shirakusa T; Enatsu S; Maekawa S; Yoshida Y; Yoshinaga Y
Thorac Cardiovasc Surg; 2005 Jun; 53(3):162-7. PubMed ID: 15926096
[TBL] [Abstract][Full Text] [Related]
27. Analysis of the molecular expression profile of non small cell lung carcinoma associated to chronic obstructive pulmonary disease.
Garcia-Lujan R; Conde-Gallego E; Lopez-Ríos F; Martin de Nicolas JL; Sanchez-Céspedes M; García-Quero C; Echave-Sustaeta JM; Lopez-Encuentra A
Histol Histopathol; 2009 Apr; 24(4):417-23. PubMed ID: 19224444
[TBL] [Abstract][Full Text] [Related]
28. Incidence, treatment options, and outcomes of lung cancer in patients with chronic obstructive pulmonary disease.
Schroedl C; Kalhan R
Curr Opin Pulm Med; 2012 Mar; 18(2):131-7. PubMed ID: 22262137
[TBL] [Abstract][Full Text] [Related]
29. DNA Methylation in Chronic Obstructive Pulmonary Disease.
Chen X; Yan F; Lin X; Shi L; Wang X; Zeng Y
Adv Exp Med Biol; 2020; 1255():83-98. PubMed ID: 32949392
[TBL] [Abstract][Full Text] [Related]
30. Novel aspects of pathogenesis and regeneration mechanisms in COPD.
Bagdonas E; Raudoniute J; Bruzauskaite I; Aldonyte R
Int J Chron Obstruct Pulmon Dis; 2015; 10():995-1013. PubMed ID: 26082624
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of IL-17A/F from human lung tissue explants with cigarette smoke exposure: implications for COPD.
Chang Y; Al-Alwan L; Alshakfa S; Audusseau S; Mogas AK; Chouiali F; Nair P; Baglole CJ; Hamid Q; Eidelman DH
Respir Res; 2014 Nov; 15(1):145. PubMed ID: 25427574
[TBL] [Abstract][Full Text] [Related]
32. Focused Analysis of Exome Sequencing Data for Rare Germline Mutations in Familial and Sporadic Lung Cancer.
Liu Y; Kheradmand F; Davis CF; Scheurer ME; Wheeler D; Tsavachidis S; Armstrong G; Simpson C; Mandal D; Kupert E; Anderson M; You M; Xiong D; Pikielny C; Schwartz AG; Bailey-Wilson J; Gaba C; De Andrade M; Yang P; Pinney SM; ; Amos CI; Spitz MR
J Thorac Oncol; 2016 Jan; 11(1):52-61. PubMed ID: 26762739
[TBL] [Abstract][Full Text] [Related]
33. COPD and squamous cell lung cancer: aberrant inflammation and immunity is the common link.
Bozinovski S; Vlahos R; Anthony D; McQualter J; Anderson G; Irving L; Steinfort D
Br J Pharmacol; 2016 Feb; 173(4):635-48. PubMed ID: 26013585
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic mechanisms in COPD: implications for pathogenesis and drug discovery.
Schamberger AC; Mise N; Meiners S; Eickelberg O
Expert Opin Drug Discov; 2014 Jun; 9(6):609-28. PubMed ID: 24850530
[TBL] [Abstract][Full Text] [Related]
35. Lung cancer - a comorbidity in chronic obstructive pulmonary disease.
Roca M; Roca IC; Mihăescu T
Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):1055-62. PubMed ID: 23700888
[TBL] [Abstract][Full Text] [Related]
36. [Evaluation of occurrence frequency of circulating p53 protein in serum of patients with chronic obstructive pulmonary diseases and non-small cell lung cancer].
Targowski T; Janda P; Owczarek W; Raczka A; Jahnz-Rózyk K; Płusa T
Pol Merkur Lekarski; 2010 Apr; 28(166):265-7. PubMed ID: 20491334
[TBL] [Abstract][Full Text] [Related]
37. Genetic predisposition to chronic obstructive pulmonary disease and/or lung cancer: important considerations when evaluating risk.
El-Zein RA; Young RP; Hopkins RJ; Etzel CJ
Cancer Prev Res (Phila); 2012 Apr; 5(4):522-7. PubMed ID: 22491518
[TBL] [Abstract][Full Text] [Related]
38. A chronic obstructive pulmonary disease related signature in squamous cell lung cancer.
Boelens MC; Gustafson AM; Postma DS; Kok K; van der Vries G; van der Vlies P; Spira A; Lenburg ME; Geerlings M; Sietsma H; Timens W; van den Berg A; Groen HJ
Lung Cancer; 2011 May; 72(2):177-83. PubMed ID: 20832896
[TBL] [Abstract][Full Text] [Related]
39. COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma.
Papi A; Casoni G; Caramori G; Guzzinati I; Boschetto P; Ravenna F; Calia N; Petruzzelli S; Corbetta L; Cavallesco G; Forini E; Saetta M; Ciaccia A; Fabbri LM
Thorax; 2004 Aug; 59(8):679-81. PubMed ID: 15282388
[TBL] [Abstract][Full Text] [Related]
40. Exposing a deadly alliance: novel insights into the biological links between COPD and lung cancer.
Vermaelen K; Brusselle G
Pulm Pharmacol Ther; 2013 Oct; 26(5):544-54. PubMed ID: 23701918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
